U.S. equities closed the week with a more defensive tone as the S&P 500 and Nasdaq broke their two‑week winning streaks under pressure from stretched AI and semiconductor leaders, while the Dow managed a modest gain on the back of value and defensive buying.
Investors used recent strength in names like Nvidia Corporation (NVDA), Advanced Micro Devices Inc. (AMD), Apple Inc. (AAPL), and Microsoft Corporation (MSFT) to take profits, rotating toward cash‑generative industrials, financials, and health care as they waited for fresh macro clarity.
Vista View: We see this as a normalization phase in the AI trade rather than the end of the secular theme, with leadership broadening and dispersion increasing across sectors and tickers.
Index Scorecard: Growth Stumbles, Value Holds
- The S&P 500 Index (GSPC) finished lower on the week, giving back part of its recent gains as growth and momentum factors lost steam.
- The Nasdaq Composite (IXIC) underperformed, with high‑beta tech and semiconductor stocks bearing the brunt of AI‑valuation fatigue.
- The Dow Jones Industrial Average (DJI) edged higher, supported by more reasonably priced industrials, financials, and health care names that benefitted from the rotation away from crowded mega‑cap growth.
Investor Takeaway: Broad U.S. equity exposure remains supported, but leadership is changing beneath the surface—index‑level calm masks growing intra‑market volatility and factor rotation.
AI & Semis: Micron and Qualcomm Shine Amid Volatility
The AI complex remained the center of the equity story, but this week brought more nuance and stock‑specific differentiation.
- Micron Technology Inc. (MU) delivered a strong earnings print and upbeat guidance, fueling a sharp post‑earnings rally as investors rewarded its positioning in AI‑driven memory and data‑center demand.
- Qualcomm Inc. (QCOM) highlighted incremental AI opportunities in data‑center and edge computing, projecting meaningful new revenue streams and reigniting interest in its broader AI roadmap beyond smartphones.
- In contrast, bellwethers like Nvidia Corporation (NVDA) and Advanced Micro Devices Inc. (AMD) saw ongoing profit‑taking as investors questioned the sustainability of AI capital‑expenditure intensity and increasingly lofty expectations embedded in current valuations.
Vista View: We continue to favor AI‑exposed names where valuation, capital‑intensity, and balance‑sheet quality remain aligned with realistic adoption curves—stock selection is becoming more critical than simply owning the broad “AI basket.”
Mega‑Cap Tech: Pricing Power Meets Skepticism
Mega‑cap tech remained under scrutiny as markets weighed exceptional profitability against incremental signs of demand sensitivity and regulatory risk.
- Apple Inc. (AAPL) and Microsoft Corporation (MSFT) drew attention for further price adjustments in key software and cloud offerings, reviving debates about the limits of pricing power at scale.
- The Nasdaq 100 (NDX) reflected this tension, as gains in select AI‑hardware and chipmakers struggled to offset weakness in some platform and software names.
Investor Takeaway: Even best‑in‑class platforms can experience multiple compression when the market questions how much more pricing and AI enthusiasm can be pulled forward—multiple expansion is no longer a given.
Macro Corner: PCE Confirms “Higher for Longer”
The macro backdrop this week revolved around the latest Personal Consumption Expenditures (PCE) inflation reading, the Federal Reserve’s preferred gauge.
- The May PCE data came in hotter than the prior month but broadly in line with expectations, keeping the “bumpy disinflation” narrative intact rather than sparking a new inflation scare.
- Markets continue to price a “higher for longer” Fed stance, with little conviction behind near‑term rate‑cut hopes but also limited fear of a renewed tightening cycle.
- Rate‑sensitive assets and long‑duration growth names felt the impact as investors reassessed discount‑rate assumptions and re‑priced future cash flows more conservatively.
Vista View: The Fed remains data‑dependent, but the bar for a rapid pivot lower in rates is high. Portfolio construction should assume a longer period of restrictive policy relative to the last decade’s norm.
Sector & Style Rotation: Cash Flows Back in Focus
Rotations this week underscored a subtle but important shift in market psychology.
- Value, quality, and income factors outperformed as investors favored companies with visible cash flows, disciplined capital allocation, and more modest expectations.
- Energy, financials, and select industrials benefited from this rotation, while parts of communication services and consumer discretionary traded unevenly in response to company‑specific headlines.
- Defensive sectors such as utilities and health care provided ballast as investors looked for ballast against AI and tech volatility.
Investor Takeaway: This is an environment that rewards balance—allocations that combine selective AI exposure with durable cash‑flow franchises may offer better risk‑adjusted outcomes than an all‑in growth stance.
Cross‑Asset Check: FX, Metals, and Crypto
Cross‑asset price action provided additional context for equity investors.
- The U.S. dollar gained ground versus the euro (EURUSD), reflecting shifting growth and rate differentials and reinforcing tighter financial conditions for non‑U.S. borrowers.
- Gold and silver advanced, with gold pushing higher and silver following suit, signaling renewed demand for precious metals as both inflation hedges and alternative stores of value.
- Bitcoin (BTC‑USD) and Ether (ETH‑USD) remained in consolidation, with crypto markets treating recent rebounds as opportunities to resize risk rather than re‑enter full‑risk mode.
Vista View: Persistent dollar strength and firm precious metals highlight that macro uncertainty is far from resolved; crypto remains more of a speculative satellite allocation than a core holding for most investors.
What This Means for Investors
For now, the market narrative has shifted from “AI melt‑up” to “AI digestion.” Strong micro stories from Micron Technology Inc. (MU) and Qualcomm Inc. (QCOM) coexist with valuation and policy uncertainty for leaders like Nvidia Corporation (NVDA), Advanced Micro Devices Inc. (AMD), Apple Inc. (AAPL), Microsoft Corporation (MSFT), and other mega‑cap franchises.
The key questions heading into the second half of 2026:
- How sustainable is AI capital‑expenditure intensity from hyperscalers and enterprises?
- How quickly will PCE and other inflation gauges converge toward the Fed’s target?
- Will leadership broaden beyond a tight cluster of AI winners, or will narrow breadth re‑assert itself?
At Vista Partners, we continue to emphasize:
- Selective exposure to AI and semiconductor leaders with disciplined capital allocation and clearer visibility on incremental returns.
- Balanced sector positioning that includes financials, industrials, and defensives to temper factor and valuation risk.
- A macro‑aware framework that respects higher‑for‑longer rates and cross‑asset signals from FX, rates, and commodities.
VP Watchlist Updates
Amwell® (NYSE: AMWL) a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, closed at $9.19, +9.02% over the last 5-days.
Eupraxia Pharmaceuticals Inc. (EPRX, $6.60, +1.85% over the last 5-days), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, announced (May 5) the first Eosinophilic Esophagitis Endoscopic Reference Score (EREFS) data from its ongoing Phase 1b/2a part of the RESOLVE trial evaluating EP-104GI for the treatment of eosinophilic esophagitis (“EoE”). These data were also presented at the ongoing Digestive Disease Week (“DDW”) conference in Chicago. “The EREFS is an important, validated visual index of severity of EoE disease in the esophagus of patients. It measures edema, rings and strictures and other visible markers of disease often associated with symptoms. Today’s data demonstrated improvement in two key outcomes with EP-104GI in the treatment of EoE: first, that a full injection protocol of 20 injections resulted in more pronounced improvement than a protocol with fewer injections and less coverage area within the esophagus; second, with the higher number of injections, a consistent response in both the inflammatory and fibrotic sub scores of EREFS was observed,” said Dr. James A. Helliwell, Chief Executive Officer of Eupraxia. “This EREFS data being reported at DDW is consistent with the improvements we have seen in EoE symptoms and tissue health (EoEHSS) and suggests improvement in inflammation, fibrosis and the associated narrowing of the esophagus.”
Modular Medical, Inc. (NASDAQ: MODD, $4.94, +19.90% on Friday), a leader in innovative, patient-centric insulin delivery, announced ( June 26) that the Pivot™ tubeless insulin patch pump is now shipping to physician offices for training. Upon completion of training, these pumps will be presented to potential patients in the next few days and weeks. The Company intends to expand the roster of practices that offer Pivot over the coming months. This is another significant milestone in the deployment of Pivot. Modular Medical looks forward to updating the market when these first patients are using the pump to deliver insulin. The Pivot pump is purpose-built for adults with diabetes on daily injections who have faced cost, complexity, and usability barriers with traditional pump systems. This group represents an estimated 70% of insulin-dependent adults who remain on multiple daily injections, a multi-billion-dollar opportunity within the diabetes technology market.
MODD announced (June 24) that the Pivot™ tubeless insulin patch pump is now commercially available. This marks the start of real-world patient use, and the Company’s transition to a commercial-stage medical device company. As only the second fully electronic, tubeless insulin pump available in the United States, Pivot is designed to make pump therapy simpler to learn and easier to live with. Its removable two-part design and 3 mL reservoir, intuitive interface, and flexible, wearable form factor support everyday activities, such as showering and sports, with no battery recharging required – all while maintaining clinical accuracy and connectivity. “Reaching commercial availability is a transformational milestone that marks Modular Medical’s transition from a development-stage company to a revenue-generating commercial business,” said Jeb Besser, Chief Executive Officer of Modular Medical. “As only the second fully electronic tubeless pump on the U.S. market, Pivot is positioned to serve a large, underserved ‘almost-pumper’ population. With first shipments beginning this week, we are focused on disciplined execution, as we scale adoption and seek to build long-term value for patients and shareholders.”
On (June 4) the launch of PivotPump.com, a patient-focused website designed to support individuals seeking a simpler path to insulin pump therapy. This launch follows the Company’s receipt of U.S. Food and Drug Administration (“FDA”) clearance in April 2026 for its Pivot™ insulin delivery system. The FDA clearance represents a significant milestone in Modular Medical’s strategy to expand access to insulin pump technology, particularly among individuals historically underserved by existing solutions. The Company remains on track for commercial launch in the fall of 2026. Pivot is designed for people living with diabetes who rely on daily insulin injections, as well as those who have encountered technological, usability, or cost-related barriers with traditional pump systems. The system emphasizes simplicity and ease of use for the patient and full access to clinical information for the clinician to reduce adoption friction. The PivotPump.com website provides accessible, educational content on insulin pump therapy and highlights the Company’s focus on real-world usability and supporting patients in evaluating and adopting pump-based diabetes care.
Similarweb Ltd. (NYSE: SMWB, $5.60, +12.22% over the last 5-days), a leading digital data and analytics company powering critical business decisions, announced (June 15) that it has surpassed $300 million in Annual Recurring Revenue (ARR) and signed two multi-year enterprise contracts, each representing seven-figure ARR commitments. Collectively, these contracts represent approximately $47 million in Total Contract Value to be recognized over the next three years and were signed during the second quarter of 2026.
Triller Group Inc (Nasdaq: ILLR, $4.46,+184.08% over the last 5-days), a technology and media company operating Triller App, a social media and live-streaming platform focused on music, sports, fashion and culture, together with AGBA Group, a Hong Kong-based financial-services and platform business with longstanding operations in wealth distribution, healthcare and related services across Asia, today announced that it has entered into definitive agreements to acquire a significant position providing economic exposure to SpaceX to be held as a strategic treasury asset on the Company’s balance sheet.
The Sources
- Yahoo Finance – “Stock market today: S&P 500, Nasdaq snap 2-week win streak as AI jitters pressure tech”
https://finance.yahoo.com/markets/live/stock-market-today-sp-500-nasdaq-snap-2-week-win-streak-as-ai-jitters-pressure-tech-231347821.html[finance.yahoo] - CNBC – “Stock market today: Live updates” (June 25, 2026)
https://www.cnbc.com/2026/06/25/stock-market-today-live-updates.html[writing.wisc] - Yahoo Finance – “Stock market today: Dow, S&P 500, Nasdaq futures rise as Micron, Qualcomm ease AI jitters”
https://ca.finance.yahoo.com/news/stock-market-today-dow-sp-500-nasdaq-futures-rise-as-micron-qualcomm-ease-ai-jitters-232650645.html[ca.finance.yahoo] - Yahoo Finance – “Stock market today: Dow rises, S&P 500 and Nasdaq slip as Micron soars, Apple drags Big Tech lower”
https://uk.finance.yahoo.com/news/stock-market-today-dow-sp-500-nasdaq-futures-rise-as-micron-qualcomm-ease-ai-jitters-232650645.html[uk.finance.yahoo] - Yahoo Finance – “Stock market today: S&P 500, Nasdaq eye rebound from tech rout with Micron in focus”
https://ca.finance.yahoo.com/news/stock-market-today-dow-sp-500-nasdaq-futures-slip-as-ai-trade-doubts-grow-230105138.html[ca.finance.yahoo] - XTB – Daily summary: “Will the S&P 500 close the week with a loss? Find out what drove the market today”
https://www.xtb.com/int/market-analysis/news-and-research/daily-summary-will-the-s-p-500-close-the-week-with-a-loss-find-out-what-drove-the-market-today[xtb] - KuCoin – “Crypto Daily Market Report – June 26, 2026”
https://www.kucoin.com/news/articles/crypto-daily-market-report-june-26-2026[kucoin]
Stay Updated with Vista Partners
Subscribe to receive market insights, investing ideas, and the latest updates directly in your inbox.
